InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: noretreat post# 559

Thursday, 01/12/2017 12:12:44 PM

Thursday, January 12, 2017 12:12:44 PM

Post# of 3881
Agree

The next good milestone will be

"RHB-104 - Crohn`s disease (Phase III)

- A second independent data and safety monitoring board (DSMB) meeting of the MAP US study is expected in the second quarter of 2017, with an interim efficacy analysis and an option for early stop for success for overwhelming efficacy."

An early stop will be a big deal for progress and SP
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News